John Byrd
MD
Professor and Chair of Internal Medicine
👥Biography 个人简介
John Byrd led many of the pivotal trials that established BTK inhibitors as transformative therapy in chronic lymphocytic leukemia and other B cell malignancies. He has been central to the clinical development of ibrutinib, acalabrutinib, and next generation BTK targeting agents. He continues to guide translational and clinical research in CLL.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 John Byrd 的研究动态
Follow John Byrd's research updates
留下邮箱，当我们发布与 John Byrd（University of Cincinnati College of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment